4,328 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
JNJ Johnson & Johnson $139.96 $375.48B Uptrend
Article Searches
Berkshire Hathaway: Are Warren Buffett & Co. Losing Their Midas Touch? https://seekingalpha.com/article/4227387-berkshire-hathaway-warren-buffett-and-co-losing-midas-touch?source=feed_sector_financial Dec 10, 2018 - Berkshire Hathaway and Warren Buffett have been known for many years to have a Midas Touch - the ability to be successful, especially the ability to make money easily.Their investment in Apple hasn't
City Council Speaker Corey Johnson calls for probe into video showing cops yanking baby from woman on the floor http://www.nydailynews.com/new-york/ny-metro-police-baby-video-20181209-story.html Dec 09, 2018 -

City Council Speaker Corey Johnson is calling for an investigation into a video posted online showing three cops pulling a young child from a mother on the floor.

“This is unacceptable, appalling and heart breaking,” Johnson tweeted Sunday. “I’d like to understand what transpired and how these...

Johnson Outdoors (JOUT) Q4 2018 Earnings Conference Call Transcript https://www.fool.com/earnings/call-transcripts/2018/12/07/johnson-outdoors-jout-q4-2018-earnings-conference.aspx?source=iedfolrf0000001 Dec 07, 2018 - JOUT earnings call for the period ending September 30, 2018.
Johnson Outdoors Inc. (JOUT) CEO Helen Johnson-Leipold on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4227069-johnson-outdoors-inc-jout-ceo-helen-johnson-leipold-q4-2018-results-earnings-call-transcript?source=feed_sector_transcripts Dec 07, 2018 - Johnson Outdoors Inc. (NASDAQ:JOUT) Q4 2018 Earnings Conference Call December 07, 2018 11:00 AM ET Executives Patricia Penman - VP of Marketing Services & Global Communication Helen Johnson-Leipol
Boeing: What Will The Dividend Increase Be Next Week? https://seekingalpha.com/article/4227041-boeing-will-dividend-increase-next-week?source=feed_all_articles Dec 07, 2018 - Boeing's total return outperformed the Dow average for my 59.0 month test period by 115.98%, which is fantastic.Boeing has increased its dividend for nine of the past 10 years and presently has a yiel
Pharma Stock Roundup: Glaxo's TESARO Buyout & Horlicks Sale, ASH Cancer Data Updates http://www.zacks.com/stock/news/341786/pharma-stock-roundup-glaxos-tesaro-buyout-horlicks-sale-ash-cancer-data-updates?cid=CS-ZC-FT-341786 Dec 07, 2018 - Glaxo (GSK) to buy TESARO and divest Horlicks brand to Unilever. ASH cancer presentations grab headilines.
Dow 30 Stock Roundup: Apple Likely to Delay 5G iPhone Launch, Exxon Finds Oil in Pluma-1 Exploration Well http://www.zacks.com/stock/news/341746/dow-30-stock-roundup-apple-likely-to-delay-5g-iphone-launch-exxon-finds-oil-in-pluma-1-exploration-well?cid=CS-ZC-FT-341746 Dec 07, 2018 - The Dow traversed a rough holiday-shortened week, marked by the return of trade war fears.
THW: Global Healthcare Fund With 10%+ Yield https://seekingalpha.com/article/4226785-thw-global-healthcare-fund-10-percent-yield?source=feed_tag_etf_portfolio_strategy Dec 06, 2018 - THW is a Tekla healthcare fund much like THQ, but with an emphasis on holding global securities.THW currently has a quite attractive 10.55% yield.This fund is also showing a discount of 8.29%, but tha
March To Freedom Fund November Update https://seekingalpha.com/article/4226715-march-freedom-fund-november-update?source=feed_all_articles Dec 06, 2018 - The March to Freedom Fund has a total return of nearly 10% for 2018.While some of our leadership stocks have changed, our laggards remain the same.We added to our Realty Income and Altria positons in
AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study http://www.zacks.com/stock/news/341638/abbvie-halts-rova-t-phase-iii-second-line-lung-cancer-study?cid=CS-ZC-FT-341638 Dec 06, 2018 - IDMC recommends AbbVie (ABBV) to stop enrolment in a late-stage study on its small cell lung cancer candidate, Rova-T.

Pages: 123456...433

Page 1>

Related Companies

Name Exchange Price Mkt Cap
PFE Pfizer, Inc. NYSE $43.01 $252.13B
NVS Novartis AG NYSE $85.13 $197.65B
MRK Merck & Company, Inc. NYSE $70.42 $187.28B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
ABT Abbott Laboratories NYSE $67.67 $118.71B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Johnson & Johnson
JNJ - Google Finance https://www.google.com/finance?q=JNJ Industry related info and international coverage Summary News
JNJ - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=JNJ Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options